Mirae Raises $5.4M in Funding

Symptoms change between appointments, but those changes often disappear from the clinical record. The platform collects that history to help patients prepare for visits and give care teams more context.

Round size
$5.4M
Stage
Undisclosed
Headquarters
United Kingdom
Announced
Jul 28, 2026

Capturing what happens between visits

Patients describe symptoms, habits and medication changes in ordinary language. The system asks follow-up questions and organises the history alongside clinical data, so a consultation can start from a fuller account than memory alone.

Developing the clinical evidence

The initial focus is inflammatory bowel disease. Work with a US health system supplies real-world patient data for model development and validation, building on research from Oxford’s Computational Health Informatics Lab.

Sources

  1. Mirae: funding announcement
  2. Mirae: legal company identity
  3. Mirae: official product
  4. Oxford Science Enterprises: company portfolio
  5. FinSMEs: funding report
03 / Related rounds

Related funding rounds

01
Series C+ · Healthtech

Neko Health

non-invasive medical scanning technology.

$700M
02
Undisclosed · AI Infrastructure

PaleBlueDot AI

PaleBlueDot AI provides cloud computing capacity for enterprise AI workloads through a unified platform for deploying and scaling compute across regions.

$255M
03
Undisclosed · Prediction markets

ProphetX

A peer-to-peer exchange for sports and other event contracts, with infrastructure for consumer trading and business partners.

Led by Parlay Capital, Data Point Capital
$35M